294 related articles for article (PubMed ID: 34076804)
41. PACE: Pharmacists use the power of communication in paediatric asthma.
Elaro A; Shah S; Pomare LN; L Armour C; Z Bosnic-Anticevich S
Int J Clin Pharm; 2014 Oct; 36(5):976-85. PubMed ID: 25087038
[TBL] [Abstract][Full Text] [Related]
42. Exploring influences on pharmacists' and students' ethical reasoning in a changing practice landscape in Australia.
Sim TF; Sunderland B; Hattingh HL
Int J Clin Pharm; 2019 Feb; 41(1):280-288. PubMed ID: 30578471
[TBL] [Abstract][Full Text] [Related]
43. Hospital pharmacists' ethical exposure and decision-making.
So B; Tuche M; King MA; Hope DL; La Caze A; Hattingh HL
Res Social Adm Pharm; 2021 Feb; 17(2):372-380. PubMed ID: 32284299
[TBL] [Abstract][Full Text] [Related]
44. Community pharmacists' perspectives on implementation of Medicines Use Review in Slovenia.
Nabergoj Makovec U; Kos M; Pisk N
Int J Clin Pharm; 2018 Oct; 40(5):1180-1188. PubMed ID: 29909563
[TBL] [Abstract][Full Text] [Related]
45. Factors influencing patient participation in medication counseling at the community pharmacy: A systematic review.
Qudah B; Thakur T; Chewning B
Res Social Adm Pharm; 2021 Nov; 17(11):1863-1876. PubMed ID: 33766505
[TBL] [Abstract][Full Text] [Related]
46. Pharmacists' perceptions of their role in asthma management and barriers to the provision of asthma services.
Kritikos VS; Reddel HK; Bosnic-Anticevich SZ
Int J Pharm Pract; 2010 Aug; 18(4):209-16. PubMed ID: 20636672
[TBL] [Abstract][Full Text] [Related]
47. Competence, competition and collaboration: Perceived challenges among Swedish community pharmacists engaging in pharmaceutical services provision and research.
Frisk P; Holtendal C; Bastholm-Rahmner P; Sporrong SK
Int J Pharm Pract; 2019 Aug; 27(4):346-354. PubMed ID: 30707481
[TBL] [Abstract][Full Text] [Related]
48. Using the behaviour change wheel to understand and address barriers to pharmacy naloxone supply in Australia.
Nielsen S; Olsen A
Int J Drug Policy; 2021 Apr; 90():103061. PubMed ID: 33321285
[TBL] [Abstract][Full Text] [Related]
49. Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges.
Lee RY; Moles R; Chaar B
Contraception; 2015 Jan; 91(1):25-30. PubMed ID: 25248673
[TBL] [Abstract][Full Text] [Related]
50. Direct-to-consumer advertising: Australian pharmacists' experiences with non-prescription medicines.
Chaar B; Kwong K
Int J Pharm Pract; 2010 Feb; 18(1):43-50. PubMed ID: 20405595
[TBL] [Abstract][Full Text] [Related]
51. Is there a time and place for health education in chain pharmacies? Perspectives of Polish community pharmacists.
Cerbin-Koczorowska M; Przymuszala P; Zielinska-Tomczak L; Wawrzyniak E; Marciniak R
Health Soc Care Community; 2021 Sep; 29(5):e56-e66. PubMed ID: 33247859
[TBL] [Abstract][Full Text] [Related]
52. Rural pharmacists and stakeholders perspectives of expanded pharmacy practice: A descriptive study.
Taylor SM; Cairns A; Glass BD
Aust J Rural Health; 2021 Jun; 29(3):341-353. PubMed ID: 34148266
[TBL] [Abstract][Full Text] [Related]
53. Implementation of diabetes screening in community pharmacy - factors influencing successful implementation.
Siu AHY; Krass I; Mitchell B; McNamara K
Res Social Adm Pharm; 2021 Sep; 17(9):1606-1613. PubMed ID: 33414090
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
55. Factors affecting pharmacists' recommendation of complementary medicines - a qualitative pilot study of Australian pharmacists.
Culverhouse SE; Wohlmuth H
BMC Complement Altern Med; 2012 Oct; 12():183. PubMed ID: 23051066
[TBL] [Abstract][Full Text] [Related]
56. Pharmacists' views on Indigenous health: is there more that can be done?
Stoneman J; Taylor SJ
Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
[TBL] [Abstract][Full Text] [Related]
57. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
[TBL] [Abstract][Full Text] [Related]
58. Pharmacist peer coaching in a traditional community chain pharmacy: Implementation and perceptions.
Hake KL; Carroll JC; Somma McGivney MA; Coley KC
J Am Pharm Assoc (2003); 2021; 61(4S):S85-S90. PubMed ID: 33781696
[TBL] [Abstract][Full Text] [Related]
59. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
[TBL] [Abstract][Full Text] [Related]
60. From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies.
Murphy AL; Martin-Misener R; Kutcher SP; O'Reilly CL; Chen TF; Gardner DM
BMC Health Serv Res; 2016 Oct; 16(1):569. PubMed ID: 27729051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
